Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Beard hair follicles have more androgen receptors than non-balding scalp hair follicles.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Higher androgen levels and site-specific AR expression cause sex-related skeletal differences, and certain steroids can boost AR expression and androgen effects in bone cells.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Lowering testosterone speeds up wound healing in male mice.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Spearmint tea may reduce testosterone and self-reported hair growth in women with PCOS.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

A new gene, JMJD1C, may affect testosterone levels in men.

High-dose androgen therapy can help manage certain types of androgen resistance.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Androgens slow hair growth by altering Wnt signaling in balding cells.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

A subtle androgen receptor abnormality can allow normal male development and sometimes fertility despite partial androgen resistance.